Projects per year
Personal profile
Education
- 2002 PhD, Department of Physiology, University of Oxford
Experience
- 1998~Present Attending Physician, Department of Obstetrics and Gynecology, National Cheng Kung University Hospital
- 2011~2012 Elected Visiting Fellow, Corpus Christi College, Oxford, United Kingdom
- 2011~Present Distinguished Professor, Departments of Pharmacology, Obstetrics and Gynecology, College of Medicine, National Cheng Kung University
- 2013~2019 Associate Dean for Research, College of Medicine, National Cheng Kung University
- 2014~2017 Chairman, Department of Pharmacology, National Cheng Kung University
- 2015~2016 Coordinator for Pharmacology, Toxicology, Medicinal Biochemistry & Molecular Biology, Ministry of Science and Technology
- 2016~2019 Deputy Superintendent, National Cheng Kung University Hospital
- 2019/08~Present Superintendent, National Cheng Kung University Hospital
Research Interests
- Genomic medicine
- Drug development
- Molecular biology
- Cellular physiology
Fingerprint
Dive into the research topics where Meng-Ru Shen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Cd40 pathway and il-2 expression mediate the differential outcome of colorectal cancer patients with different csf1r c.1085 genotypes
Yeh, Y. M., Lin, P. C., Su, W. C. & Shen, M. R., 2021 Nov 1, In: International journal of molecular sciences. 22, 22, 12565.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
Chan, R. H., Lin, P. C., Chen, S. H., Lin, S. C., Chen, P. C., Lin, B. W., Shen, M. R. & Yeh, Y. M., 2021 Mar 19, In: Frontiers in Oncology. 11, 589673.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients
Lin, P. C., Chen, H. O., Lee, C. J., Yeh, Y. M., Shen, M. R. & Chiang, J. H., 2021 Dec, In: Human Genomics. 15, 1, 3.Research output: Contribution to journal › Article › peer-review
Open Access -
Comprehensively exploring the mutational landscape and patterns of genomic evolution in hypermutated cancers
Lin, P. C., Yeh, Y. M., Hsu, H. P., Chan, R. H., Lin, B. W., Chen, P. C., Pan, C. C., Hsu, K. F., Hsiao, J. R., Shan, Y. S. & Shen, M. R., 2021 Sep 1, In: Cancers. 13, 17, 4317.Research output: Contribution to journal › Article › peer-review
Open Access -
Memantine protects against paclitaxel-induced cognitive impairment through modulation of neurogenesis and inflammation in mice
Sung, P. S., Chen, P. W., Yen, C. J., Shen, M. R., Chen, C. H., Tsai, K. J. & Lin, C. C. K., 2021 Aug 2, In: Cancers. 13, 16, 4177.Research output: Contribution to journal › Article › peer-review
Open Access